pioneering proteins launch
This Qkine post page covers “pioneering proteins launch” covering pioneering proteins launch, GMP recombinant proteins, animal-origin-free growth factors, cytokines for…
News
Celebrating International Women’s Day 2021 with our amazing team, collaborators, customers and wider network
At Qkine we are so proud of all the wonderful women we work with! This #InternationalWomensDay we want to celebrate our amazing network and empower #WomenInSTEM to learn from and help each other #empoweringwomen #womenpower
Catherine Elton, Qkine founder and CEO, recognised in the #21towatch in 2021
The #21toWatch campaign showcases 7 people, 7 companies and 7 inventions at the forefront of innovation in Cambridge and the East of England. The results were announced on the 4th March and we are delighted that our CEO, Catherine Elton, was named one of the 7 “people” to watch.
Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK
Qkine, Manchester BIOGEL and Cellesce have been awarded Innovate UK Sustainable Innovation Funding to develop fully synthetic, chemically-defined three-dimensional (3D) scaffolds to enable manufacture scale up and improve reproducibility of patient-derived organoids.
Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards
Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards Qkine is delighted to have been shortlisted in the prestigious Cambridge Independent…
Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board
Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board Cambridge, UK 21 July 2020: Qkine – a specialist developer and manufacturer…
Qkine secures £1.5M series A funding from leading life science investors
Qkine secures £1.5M series A funding from leading life science investors Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for…
Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio
Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio Cambridge, UK 03 June 2019: Qkine, specialist…
So what does the “i” in iteams mean?
So what does the “i” in iteams mean? Running for over a decade, the iteams programme partners multi-disciplinary teams of PhD students and postdocs with inventors from…
Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK
We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for use in organoid technologies. The Qkine R&D team are applying a combination of protein expression, refolding optimisation and structure-guided protein engineering to improve the biological properties and quality of proteins such as R-spondins, TGFβ1, members of the BMP and FGF family proteins.
Qkine backed by Cambridge Enterprise and a quintet of angels
Qkine backed by Cambridge Enterprise and a quintet of angels University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge…
Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research
Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology
- « Previous
- 1
- …
- 5
- 6
- 7
